Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immune Therapeutics Inc (OTCQB:IMUN)

0.1185
Delayed Data
As of Aug 26
 +0.0036 / +3.13%
Today’s Change
0.07
Today|||52-Week Range
0.36
-46.11%
Year-to-Date
No recent news for Immune Therapeutics Inc.

Today’s Trading

Previous close0.11
Today’s open0.11
Day’s range0.11 - 0.13
Volume835,128
Average volume (3 months)265,407
Market cap$26.2M
Dividend yield--
Data as of 3:12pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+77.55%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales2,080.57
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting dateMay 29, 2013
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$16.2K
Annual profit (last year)-$16.3M
Net profit margin-100,721.10%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Noreen Griffin
Chief Operating Officer &
Director
Christopher Pearce
Corporate headquarters
Orlando, Florida

Forecasts

Partner Offers

Search for Jobs